HCA Healthcare, Inc. (NYSE:HCA) Stock Position Lowered by Mackenzie Financial Corp

Mackenzie Financial Corp lessened its stake in HCA Healthcare, Inc. (NYSE:HCA) by 16.8% during the 1st quarter, Holdings Channel reports. The institutional investor owned 108,127 shares of the company’s stock after selling 21,845 shares during the quarter. Mackenzie Financial Corp’s holdings in HCA Healthcare were worth $37,363,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the business. Sanders Capital LLC increased its stake in shares of HCA Healthcare by 1.0% during the 4th quarter. Sanders Capital LLC now owns 11,655,563 shares of the company’s stock worth $3,498,417,000 after purchasing an additional 116,826 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of HCA Healthcare by 1.3% during the 4th quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company’s stock worth $1,159,882,000 after purchasing an additional 50,321 shares during the last quarter. Capital World Investors increased its stake in shares of HCA Healthcare by 0.7% during the 4th quarter. Capital World Investors now owns 2,928,452 shares of the company’s stock worth $878,975,000 after purchasing an additional 19,121 shares during the last quarter. Northern Trust Corp grew its stake in HCA Healthcare by 12.4% in the 4th quarter. Northern Trust Corp now owns 2,017,971 shares of the company’s stock valued at $605,694,000 after buying an additional 223,248 shares during the last quarter. Finally, Nuveen Asset Management LLC grew its stake in HCA Healthcare by 4.5% in the 4th quarter. Nuveen Asset Management LLC now owns 1,865,771 shares of the company’s stock valued at $560,011,000 after buying an additional 81,105 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insiders Place Their Bets

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the firm’s stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer owned 12,646 shares in the company, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 1.30% of the company’s stock.

HCA Healthcare Trading Up 1.2%

Shares of HCA stock opened at $344.52 on Wednesday. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The company has a market capitalization of $82.88 billion, a P/E ratio of 14.48, a P/E/G ratio of 1.14 and a beta of 1.47. The firm has a 50-day moving average price of $372.05 and a 200 day moving average price of $346.40. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm’s quarterly revenue was up 6.4% on a year-over-year basis. During the same period last year, the firm posted $5.50 EPS. Research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.84%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare’s payout ratio is presently 12.11%.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Barclays lowered their target price on shares of HCA Healthcare from $416.00 to $390.00 and set an “overweight” rating on the stock in a research note on Monday. Royal Bank Of Canada lowered their target price on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating on the stock in a research note on Monday. Bank of America lowered shares of HCA Healthcare from a “buy” rating to a “neutral” rating and set a $394.00 price target on the stock. in a research report on Wednesday, July 16th. Wells Fargo & Company upgraded shares of HCA Healthcare from an “underweight” rating to an “equal weight” rating and raised their price target for the stock from $320.00 to $385.00 in a research report on Thursday, May 29th. Finally, Baird R W lowered shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 15th. Nine equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $396.46.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.